Προωθημένο
Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective cancer therapies. Although...
0 Σχόλια 0 Μοιράστηκε 25 Views 0 Προεπισκόπηση